|
METTL4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.814070E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.019200E-01 |
| Normal-vs-Stage2 |
5.284400E-01 |
| Normal-vs-Stage3 |
2.953700E-04 |
| Normal-vs-Stage4 |
2.522800E-03 |
| Stage1-vs-Stage2 |
9.598400E-01 |
| Stage1-vs-Stage3 |
1.659010E-03 |
| Stage1-vs-Stage4 |
1.754110E-02 |
| Stage2-vs-Stage3 |
4.175700E-02 |
| Stage2-vs-Stage4 |
9.867900E-02 |
| Stage3-vs-Stage4 |
6.634200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.206200E-02 |
| Normal-vs-AfricanAmerican |
1.065970E-01 |
| Normal-vs-Asian |
1.474970E-01 |
| Caucasian-vs-AfricanAmerican |
8.979000E-01 |
| Caucasian-vs-Asian |
6.364000E-01 |
| AfricanAmerican-vs-Asian |
6.577400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.977100E-03 |
| Normal-vs-Female |
1.607960E-01 |
| Male-vs-Female |
3.059000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.296100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.094000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.161800E-03 |
| Normal-vs-Age(81-100Yrs) |
6.104300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.899400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.931400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.182400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.147700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.591800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.000600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.578620E-01 |
| Normal-vs-Grade 2 |
9.718200E-01 |
| Normal-vs-Grade 3 |
4.164800E-04 |
| Normal-vs-Grade 4 |
2.09980000054344E-07 |
| Grade 1-vs-Grade 2 |
1.558360E-01 |
| Grade 1-vs-Grade 3 |
1.563730E-02 |
| Grade 1-vs-Grade 4 |
2.14049999999189E-05 |
| Grade 2-vs-Grade 3 |
1.007570E-04 |
| Grade 2-vs-Grade 4 |
6.80770000371922E-08 |
| Grade 3-vs-Grade 4 |
5.883600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.341800E-01 |
| Normal-vs-ccB subtype |
3.8516000000044E-05 |
| ccA subtype-vs-ccB subtype |
2.5553000004841E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.064230E-01 |
| Normal-vs-N1 |
2.780400E-02 |
| N0-vs-N1 |
2.830000E-01 |
|
|
